BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23507699)

  • 1. Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies.
    Rocha V; Labopin M; Ruggeri A; Podestà M; Gallamini A; Bonifazi F; Sanchez-Guijo FM; Rovira M; Socie G; Baltadakis I; Michallet M; Deconinck E; Bacigalupo A; Mohty M; Gluckman E; Frassoni F
    Transplantation; 2013 May; 95(10):1284-91. PubMed ID: 23507699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.
    Chen YH; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Huang XJ; Liu KY
    Chin Med J (Engl); 2013 Jul; 126(13):2499-503. PubMed ID: 23823825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants.
    Page KM; Zhang L; Mendizabal A; Wease S; Carter S; Gentry T; Balber AE; Kurtzberg J
    Biol Blood Marrow Transplant; 2011 Sep; 17(9):1362-74. PubMed ID: 21277377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of unrelated umbilical cord blood transplantation for 25 patients with hematological diseases].
    Chang HR; Cheng Z; Chen GH; Sun AN; Qiao M; Ma X; Wang Y; Chen F; Jin HY; Lu Y; Zhang JQ; Fu CC; Jin ZM; Tang XW; Han Y; Qiu HY; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):767-73. PubMed ID: 24989292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double umbilical cord blood transplantation for hematological malignancies: a long-term analysis from the SFGM-TC registry.
    Wallet HL; Sobh M; Morisset S; Robin M; Fegueux N; Fürst S; Mohty M; Deconinck E; Fouillard L; Bordigoni P; Rio B; Sirvent A; Renaud M; Dhedin N; Tabrizi R; Maury S; Buzyn A; Michel G; Maillard N; Cahn JY; Bay JO; Yakoub-Agha I; Huynh A; Schmidt-Tanguy A; Lamy T; Lioure B; Raus N; Marry E; Garnier F; Balère ML; Gluckman E; Rocha V; Socié G; Blaise D; Milpied N; Michallet M
    Exp Hematol; 2013 Nov; 41(11):924-33. PubMed ID: 23831606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unrelated umbilical cord blood transplantation with TBI/Ara-c/CY non-ATG conditioning regimen for adults with hematologic malignancies].
    Sun ZM; Liu HL; Geng LQ; Zhou CY; Wang XB; Ding KY; Tong J; Zhu WB; Liu X; Wang ZY
    Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(24):1660-4. PubMed ID: 22944153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia.
    Sanz J; Montesinos P; Saavedra S; Lorenzo I; Senent L; Planelles D; Larrea L; Martín G; Palau J; Jarque I; Martínez J; de la Rubia J; Moscardó F; Martinez D; Gómez I; López M; Sanz MA; Sanz GF
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1589-95. PubMed ID: 20553927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.
    Wang X; Liu H; Li L; Geng L; Ding K; Liu X; Tong J; Zhu W; Sun Z
    Eur J Haematol; 2012 Jan; 88(1):39-45. PubMed ID: 21933279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP-EBMT analysis.
    Ruggeri A; Michel G; Dalle JH; Caniglia M; Locatelli F; Campos A; de Heredia CD; Mohty M; Hurtado JM; Bierings M; Bittencourt H; Mauad M; Purtill D; Cunha R; Kabbara N; Gluckman E; Labopin M; Peters C; Rocha V
    Leukemia; 2012 Dec; 26(12):2455-61. PubMed ID: 22555150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.
    Rodrigues CA; Sanz G; Brunstein CG; Sanz J; Wagner JE; Renaud M; de Lima M; Cairo MS; Fürst S; Rio B; Dalley C; Carreras E; Harousseau JL; Mohty M; Taveira D; Dreger P; Sureda A; Gluckman E; Rocha V
    J Clin Oncol; 2009 Jan; 27(2):256-63. PubMed ID: 19064984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor.
    Magro E; Regidor C; Cabrera R; Sanjuán I; Forès R; Garcia-Marco JA; Ruiz E; Gil S; Bautista G; Millán I; Madrigal A; Fernandez MN
    Haematologica; 2006 May; 91(5):640-8. PubMed ID: 16670070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes.
    Bradstock K; Hertzberg M; Kerridge I; Svennilson J; George B; McGurgan M; Huang G; Antonenas V; Gottlieb D
    Intern Med J; 2009 Nov; 39(11):744-51. PubMed ID: 19220530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen.
    Sanz J; Boluda JC; Martín C; González M; Ferrá C; Serrano D; de Heredia CD; Barrenetxea C; Martinez AM; Solano C; Sanz MA; Sanz GF;
    Bone Marrow Transplant; 2012 Oct; 47(10):1287-93. PubMed ID: 22327127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effect of umbilical cord blood transplantation in 37 pediatric patients with hematologic malignancies: a single-center experience].
    Luan Z; Tang XF; Wu NH; Xu SX; Zhang B; Wang K; Du H
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):714-9. PubMed ID: 25008879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unrelated cord blood transplants in adults with hematologic malignancies.
    Arcese W; Rocha V; Labopin M; Sanz G; Iori AP; de Lima M; Sirvent A; Busca A; Asano S; Ionescu I; Wernet P; Gluckman E;
    Haematologica; 2006 Feb; 91(2):223-30. PubMed ID: 16461307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-unit cord blood transplantation after myeloablative conditioning for patients with hematologic malignancies: a multicenter phase II study in Japan.
    Kai S; Wake A; Okada M; Kurata M; Atsuta Y; Ishikawa J; Nakamae H; Aotsuka N; Kasai M; Misawa M; Taniguchi S; Kato S
    Biol Blood Marrow Transplant; 2013 May; 19(5):812-9. PubMed ID: 23416856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation.
    Peffault de Latour R; Purtill D; Ruggeri A; Sanz G; Michel G; Gandemer V; Maury S; Kurtzberg J; Bonfim C; Aljurf M; Gluckman E; Socié G; Passweg J; Rocha V
    Biol Blood Marrow Transplant; 2011 Jan; 17(1):78-85. PubMed ID: 20561593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes in adults with leukemia treated with transplantation of two unrelated umbilical cord blood units.
    Yin Y; Ren HY; Cen XA; Qiu ZX; Ou JP; Wang WS; Wang MJ; Xu WL; Wang LH; Li Y; Dong YJ
    Chin Med J (Engl); 2011 Aug; 124(16):2411-6. PubMed ID: 21933579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival.
    Gluckman E; Rocha V; Ionescu I; Bierings M; Harris RE; Wagner J; Kurtzberg J; Champagne MA; Bonfim C; Bittencourt M; Darbyshire P; Fernandez MN; Locatelli F; Pasquini R;
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1073-82. PubMed ID: 17697970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation.
    Sanz J; Picardi A; Hernández Boluda JC; Martín C; Ferrá C; Nozzoli C; Gonzalez-Vicent M; Rambaldi A; Valcarcel D; Verdeguer A; Serrano D; de Heredia CD; Pascual MJ; de Paz R; Montesinos P; Bartolozzi B; Algarotti A; Sanz MA; Arcese W; Sanz GF;
    Biol Blood Marrow Transplant; 2013 Sep; 19(9):1387-92. PubMed ID: 23850652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.